Clinical Trial Update: Randomized, Placebo-Controlled Trial of N-acetylcysteine In Parkinson's Disease Patients: A Pilot Study [Phase 2]

View source ↗

Summary

This entry notes the completion of a Phase 2 randomized, placebo-controlled trial of N-acetylcysteine in patients with Parkinson's disease. The sponsor is Kurdi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• N-acetylcysteine (N-acetylcysteine)

Snippet

Sponsor: Kurdistan University of Medical Sciences | Conditions: Parkinson's Disease (PD) | Phase 2 | Status: COMPLETED